The phenotypic differences between GTBP and hMSH2 mutants were partially explained by the biochemical experiments of Drummond et al. [2] , who showed that LoVo cell extracts, which lack hMSH2, were unable to process a G/T mismatch or a loop of two extrahelical nucleotides. By contrast, DLDl/HCT15 extracts, which lack GTBP, could partially process a dinucleotide (TG) loop. Although the deficiency in base-base mismatch and loop repair could be complemented by adding purified hMutS␣, which directly demonstrated that the hMSH2-GTBP heterodimer also functions in loop repair, these results implied that the repair of loops of two or more nucleotides absolutely requires hMSH2, but not GTBP. We therefore considered the possibility that hMSH2 alone might be the loopbinding factor, as reported previously [8, 9] . We could reproduce these latter experiments in our laboratory, using protein purified from a Baculovirus expression system. However, in our hands, mismatch-binding activity was only seen in the absence of non-specific competitor DNA, and at a protein concentration around 100 nM (data not shown), which was approximately two orders of magnitude greater than that of hMutS␣, even under experimental conditions where non-specific competitor was present (see below).
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We therefore set out to test the hypothesis [10] that loop recognition is mediated by a factor distinct from hMutS␣, most probably a complex between hMSH2 and a second, as yet unknown, protein. What could be this missing partner of hMSH2? We turned our attention to the first described human MutS homolog, hMSH3, also known as DUP1 [11] or MRP1 [12] , as recent data showed that mutation of MSH3, which encodes the Saccharomyces cerevisiae homolog of hMSH3, results in a limited microsatellite instability [13] and a weak mutator phenotype [14] . We investigated the ability of hMSH3 to interact with hMSH2, and studied the affinity of the resulting complex for substrates containing loops and base-base mismatches. We also compared the substrate specificity of the hMSH3-hMSH2 complex with that of hMutS␣.
The putative hMSH3-containing loop-binding factor is not very abundant, as demonstrated by the fact that hMSH3 was undetectable in western blots of human cell extracts probed with polyclonal rabbit or mouse anti-hMSH3 antisera (data not shown). This might explain why no activity able to specifically bind to loops of two or more nucleotides has been detected by band-shift assays using unfractionated cell extracts lacking hMutS␣. We therefore decided to express hMSH3, GTBP and hMSH2, either alone or in combination, in the Baculovirus system and to study the substrate specificity of the purified individual proteins and the heterodimeric complexes. Expression of baculovirus-expressed hMSH3 in Sf9 cells yielded predominantly insoluble protein aggregates (data not shown). However, co-infection with viral vectors encoding hMSH2 and hMSH3 resulted in the production of soluble proteins, which co-purified by chromatography on heparinSepharose as an equimolar mixture of polypeptides of approximate molecular weights of 107 and 131 kDa (Fig.  1 ). This corresponded very well with the expected sizes of hMSH2 (105 kDa) and hMSH3 (127 kDa) calculated from their amino-acid compositions. A similar purification strategy, using extracts of Sf9 cells co-infected with vectors expressing GTBP and hMSH2, yielded the hMutS␣ heterodimer ( Fig. 1) , composed of GTBP (apparent and calculated molecular weights 167 kDa and 153 kDa, respectively) and hMSH2.
The finding that hMSH2 and hMSH3 co-purified in a similar way to hMutS␣ [2] , eluting from single-stranded DNA-Sepharose with ATP, suggested that the two proteins also exist in a complex. Two additional experiments supported this prediction: first, polyclonal anti-hMSH2 antiserum immunoprecipitated hMSH3 from extracts of Sf9 cells that co-expressed hMSH3 and hMSH2 (Fig. 2 , lane 5), but not from extracts from cells expressing hMSH3 only (Fig. 2, lane 4) ; second, gel-filtration experiments similar to those described previously [2] showed that hMutS␣ and hMSH2-hMSH3 both eluted with a similar retention time from a S-200 Sephacryl FPLC column, with an approximate molecular weight of 250 kDa (data not shown). As hMSH2-hMSH3 and hMutS␣ showed similar ATP-sensitive DNA binding in band-shift assays ( [2, 15] ; data not shown) we named it hMutS␤.
We next examined the ability of the two heterodimeric complexes to bind to substrates containing mismatches or extrahelical nucleotides. Figure 3 shows that purified Baculovirus-expressed hMutS␣ had the highest affinity for substrates containing a G/T mispair and a single extrahelical thymine (see also [2] ), whereas loops of two, three or four nucleotides were bound with a significantly lower efficiency in the band-shift assay. In contrast, purified hMutS␤ had a clear preference for loops of two or more nucleotides ( Fig. 3 ; substrates are shown in Fig. 4b ).
The efficiency of loop recognition by the two factors seemed to vary according to the extrahelical nucleotides and their flanking sequences. Thus, although the affinity of hMutS␤ for the two-nucleotide GT loop was about five times higher than that of hMutS␣, the GT loop in substrate I was bound better by hMutS␣ (Fig. 4) . Interestingly, the substrates that were bound poorly by one factor were generally better substrates for the other heterodimer, which further implies that hMutS␣ and hMutS␤ are functionally redundant, at least to some extent [2] .
These preliminary studies of substrate specificity show that hMutS␣ and hMutS␤ complement one another in loop recognition. As its name implies, postreplicative mismatch repair must address all errors of DNA replication, be they base-base mismatches or loops. It seems likely that, under normal circumstances, hMutS␣ plays the major The results of Drummond et al. [2] showed that hMutS␣ is functional in two-nucleotide loop repair, as shown by the fact that addition of the purified heterodimer to extracts of mismatch repair-deficient LoVo cells restores the repair of a G/T mismatch and a two-nucleotide loop. Their experiments also showed that hMutS␣ is not essential for loop repair, as extracts from GTBP mutants were partially proficient in loop repair [2] . This implied that loop repair can also be mediated by a GTBP-independent factor and we anticipated that this factor could be hMutS␤. This hypothesis seems to be correct, as our preliminary data show that purified hMutS␤ can restore loop repair (but not base-base mismatch repair) to LoVo extracts (J. Drummond, P. Modrich, F.P., I.I., E.N., M.I., T.S. and J.J., unpublished observations).
Does hMutS␤ really play a role in loop repair and microsatellite instability? As MSH3 is involved in mismatch correction in S. cerevisiae [13, 14, 16, 17] , it seems reasonable to infer that hMSH3 will play an analogous role in mammals. Although our results represent the first experimental evidence in support of this hypothesis, more data may be forthcoming shortly, as recent RT-PCR analysis of bone marrow cells from patients with haematological malignancies identified individuals with highly variable levels of hMSH3 mRNA [12] . Although the results with yeast msh3 mutants predict that cells lacking hMSH3 will not have strong mutator phenotypes, it could be postulated that dysregulation of MSH3 transcription could have deleterious effects on mismatch repair. Thus, overexpression of hMSH3 might significantly alter the relative concentrations of hMutS␣ and hMuts␤ by sequestering hMSH2 preferentially in the latter heterodimer. As hMutS␤ does not bind to base-base mispairs, one would predict that these cells would be similar to those lacking GTBP, in demonstrating low or negligible microsatellite instability but a strong mutator phenotype. It is tempting to speculate that such clones might be generated in vivo in cancer patients treated with some anti-metabolites; for example, methotrexate treatment often leads to the amplification of the DHFR locus, which is immediately adjacent to the hMSH3 gene [11] .
These data provide us with an invaluable insight into the aetiology of HNPCC tumours. The inheritance of a mutant allele of a mismatch-repair gene predisposes individuals to cancer of the colon and/or of other tissues (see [18, 19] for recent reviews), presumably through mutation of the remaining wild-type allele and the associated conversion of the heterozygous, mismatch-repair proficient cell to one with a mutator phenotype. Assuming that mismatch repair in humans is accomplished by a mechanism resembling that proposed by Karran ( 
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Differential repair of mismatched DNA. Under normal circumstances, base-base mispairs and loops are bound by hMutS␣, which then recruits the hMutL␣ complex consisting of hMLH1 and hPMS2 [20] . When GTBP is absent, hMutS␤ compensates for the lack of hMutS␣ in loop repair, but not in the repair of base-base mispairs. The scheme is similar to that proposed in [10] . hMSH2, hMLH1 and hPMS2 would cause a complete deficiency in the repair of loops and base-base mismatches. In contrast, mutations in either GTBP or hMSH3 would not bring about a null mismatch-repair phenotype because of the functional redundancy of these proteins in loop repair. As the major difference between the mutator phenotypes of cells deficient in hMSH2 and GTBP is the propensity of the former to frameshift mutations, we infer that HNPCC tumours arise from cells that are null for loop repair. Thus, whereas only a single mutation would be required in the case of the hMSH2, hMLH1 and hPMS2 genes, both hMSH3 and GTBP would have to be mutated to give rise to a similar phenotype. As this event is statistically highly improbable, we propose that mutations in hMSH3 and GTBP will not be found in HNPCC tumours.
The Baculovirus technology described here should also lead to rapid developments in the study of the MutL homologs. To date, mutations in HNPCC tumours have been linked with hMLH1, hPMS2 and hPMS1, although only the former two, in the form of a hMutL␣ heterodimer have been ascribed a role in mismatch repair [20] . The difficulties associated with the purification of the hMutL␣ complex from human cells, as well as the study of the possible biological role of the putative hMutL␤ species, could be readily overcome by overexpression of the recombinant proteins in the Baculovirus system.
Materials and methods

Baculovirus expression vectors
The GTBP, hMSH3 and hMSH2 cDNA sequences were introduced into pFastBacI vector (GIBCO-BRL) and the recombinant Baculoviruses were obtained using the Bac-To-Bac system according to the manufacturer's (GIBCO-BRL) instructions. The detailed construction of these vectors will be described elsewhere.
Purification of the mismatch-binding factors
The purification of the recombinant hMutS␣ and hMutS␤ was performed at 4°C. Total extracts of 50 × 10 6 Sf9 cells co-infected with Baculovirus vectors expressing either hMSH2 and GTBP, or hMSH2 and hMSH3, were prepared as described [21] . The extracts (12 mg, 6 mg ml -1 in HE buffer [15] containing 1 M NaCl) were passed through a DEAE-Sepharose Fast Flow column (Pharmacia), diluted to 0.3 M salt with 4 volumes of 0.05 M sodium phosphate (pH 7.0) and 2 mM ␤-mercaptoethanol, and loaded onto a 1 ml Hi-Trap heparin-Sepharose FPLC column (Pharmacia). The proteins were eluted with a 20 ml linear gradient of 0.3-1 M NaCl in sodium phosphate (pH 7.0) and 2 mM ␤-mercaptoethanol. The fractions containing the pure proteins were pooled, dialyzed extensively against HE buffer containing 2 mM ␤-mercaptoethanol, 10 % sucrose and 0.1 % PMSF, and stored in aliquots at -80°C. This procedure yielded 50 g of protein.
Immunoprecipitation and band-shift experiments
Total extracts of Sf9 cells singly infected or co-infected with the Baculovirus vectors expressing hMSH2 or hMSH3 were immunoprecipitated [22] with a rabbit polyclonal anti-hMSH2 antibody [1] . Sf9 extracts, immunoprecipitated proteins or purified proteins were loaded on a denaturing 7.5 % SDS-polyacrylamide gel. Following electrophoresis, the proteins were electroblotted onto a nitrocellulose membrane and allowed to react with mouse polyclonal anti-hMSH3 antiserum. The bands were visualized by staining with goat anti-mouse antibody conjugated with alkaline phosphatase (Promega). Band-shift assays were performed as described in [21] , except that 15 ng (60 fmol) of the purified factors were used per lane, in the presence of 100 ng of non-specific competitor (poly(dI.dC); Pharmacia).
